— Know what they know.
Not Investment Advice
Also trades as: NXLIW (NASDAQ) · $vol 0M

NXL Earnings

Nexalin Technology, Inc.
1W: +30.5% 1M: -7.4% 3M: +1537.1% YTD: +883.5% 1Y: +551.3% 3Y: +1121.8%
$5.73
-1.82 (-24.11%)
 
Weekly Expected Move ±42.5%
$1 $3 $6 $8 $11
NASDAQ · Healthcare · Medical - Devices · Tech Score Buy · Power 56 · $4.2M mcap · 593608 float · 3.09% daily turnover · Short 31% of daily vol
Last Earnings 2026-08-12
EPS
$-3.30
▼ Miss -10.0%
Revenue
$12K
▼ Miss -86.5%
Next Earnings 2026-11-13
EPS Estimate
$-2.34
Range: $-2.34 - $-2.34
Revenue Estimate
$90K
1 analysts

Estimate vs Actual

Earnings Surprise History

0/19
EPS Beats
3/19
Revenue Beats
0%
EPS Beat Rate
16%
Rev Beat Rate

Wall Street Forward Estimates

Quarterly
Annual

Estimate Revisions

Recent Revisions
DatePeriodFiscal DateEPS OldEPS NewChangeRev OldRev New
2026-10-02 annual 2026-12-31 $-11.40 $-11.42 ▼ 0.02 $345,000 $192,111
2026-10-02 quarter 2027-03-30 $— $-2.22 ▼ 2.22 $— $45,000
2026-10-02 quarter 2027-09-30 $— $-1.79 ▼ 1.79 $— $112,500
2026-10-02 quarter 2026-12-30 $-2.70 $-2.34 ▲ 0.36 $150,000 $90,000
2026-10-02 quarter 2027-06-30 $— $-2.13 ▼ 2.13 $— $45,000
2026-10-02 annual 2027-12-31 $-9.30 $-7.55 ▲ 1.75 $690,000 $337,500
2026-10-02 quarter 2027-12-30 $— $-1.59 ▼ 1.59 $— $135,000
2026-10-02 quarter 2026-09-30 $-2.70 $-2.91 ▼ 0.21 $90,000 $75,000
2026-09-30 quarter 2024-09-30 $-0.12 $1.54 ▲ 1.66 $30,000 $30,000
2026-09-01 annual 2025-12-31 $-0.49 $-14.70 ▼ 14.21 $231,000 $231,000
2026-09-01 quarter 2025-09-30 $-0.12 $-3.60 ▼ 3.48 $40,000 $40,000
2026-09-01 quarter 2024-12-31 $-0.12 $-3.60 ▼ 3.48 $30,000 $30,000
2026-09-01 quarter 2025-06-30 $-0.10 $-3.00 ▼ 2.90 $71,000 $71,000
2026-09-01 quarter 2026-03-31 $-0.11 $-3.30 ▼ 3.19 $15,000 $15,000
2026-09-01 annual 2024-12-31 $-0.61 $-18.30 ▼ 17.69 $172,000 $172,000
Earnings Call Transcripts
No transcripts available.

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms